A Trump administration adviser and key figure in a dark money effort to tie the 340B program to immigration growth, [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
A key U.S. senator on 340B policy continued to raise concerns this week about the current state of the drug [...] …
Tennessee covered entities must now submit claims data for all Boehringer Ingelheim (BI) 340B drugs filled by their in-house pharmacies [...] …
The Trump administration this month urged a Washington D.C. federal court to uphold a 2013 Health Resources and Services Administration [...] …
The Vermont House on Friday approved a 340B contract pharmacy access bill with Senate-backed hospital reporting requirements and a new [...] …
A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added another major [...] …
A California-based drugmaker this week updated its contract pharmacy restrictions to impose new claims data submissions for hospitals and prevent [...] …
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. told a U.S. Senate subcommittee Tuesday that the 340B program [...] …
A pharmaceutical industry-funded HIV/AIDS advocacy group is taking aim at the 340B program—questioning if it’s “too big to fail”—in a [...] …
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.’s first public remarks on the 340B program—which 340B Report broke [...] …